This protocol is judged by an institutional critique board, an impartial team that critiques any clinical trials involving people. If a review consists of a Routine I drug, after the board approves the protocol as ethical, the researchers really need to apply for an investigational new drug (IND) range with the FDA.Weiser urged social networking p